Benefit of standard versus low-dose tirofiban for percutaneous coronary intervention in very elderly patients with high-risk acute coronary syndrome
2016 ◽
Vol 12
(2)
◽
pp. 41-47
2011 ◽
Vol 57
(14)
◽
pp. E1769
2022 ◽
Vol 14
(1)
◽
pp. 21-22
2018 ◽
Vol 71
(16)
◽
pp. S50